Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pall, Celltheon Form Strategic Biotherapeutics Pact | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Pall, Celltheon Form Strategic Biotherapeutics Pact

To align Pall Biotech equipment and consumables with the Celltheon SMART Expression Platform

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pall Corp. has formed a strategic partnership with Celltheon Corp., a cell line and expression technology platform development company, to align Pall Biotech equipment and consumables with the Celltheon SMART Expression Platform to provide integrated manufacturing solutions for biotherapeutics.
 
“The Pall Biotech portfolio was built to support drug manufacturers at all stages of biotherapeutic molecule development and processes to improve biologic production, and ultimately, global health,” said Mario Philips, vice president and general manager of Pall Biotech. “Pall’s strategic partnerships, such as this one with Celltheon, aim to overcome manufacturing challenges with efficient, integrated and cost-effective total solutions.”
 
“The CELLTHEON SMART Expression Platform is an off-the-shelf, fully validated mammalian cell platform used to develop biologics and it is well complemented by the Pall Biotech line of equipment and services,” said Amita Goel, chief executive officer, founder and chairman of Celltheon. “With the complementary Celltheon and Pall technologies, we can provide an integrated end-to-end solution for research and bioproduction that is cost effective and time efficient. This partnership with Pall Corporation is in line with Celltheon’s mission to expedite drug development and provide solutions for unmet needs in bioprocessing.”
 
Through the agreement, Celltheon customers will have immediate access to various Pall Biotech upstream and downstream processing technologies, including bioreactors, mixing and storage, downstream technologies, and consumables.
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics